Cargando…

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma

BACKGROUND: Urothelial carcinoma (UC) is the ninth most commonly diagnosed cancer worldwide, with a 3.8/1 male to female ratio. Platinum-based chemotherapy is the first line standard of care for fit patients with advanced UC. However, despite a response rate (RR) for approximately half of patients r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coquan, Elodie, Clarisse, Bénédicte, Lequesne, Justine, Brachet, Pierre-Emmanuel, Nevière, Zoé, Meriaux, Emeline, Bonnet, Isabelle, Castera, Marie, Goardon, Nicolas, Boutrois, Jeremy, Travers, Romain, Joly, Florence, Grellard, Jean-Michel, Thiery-Vuillemin, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700963/ https://www.ncbi.nlm.nih.gov/pubmed/36434554 http://dx.doi.org/10.1186/s12885-022-10216-z

Ejemplares similares

CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
por: Coquan, Elodie, et al.
Publicado: (2021)

Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations
por: Neviere, Zoé, et al.
Publicado: (2022)

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
por: Lesueur, Paul, et al.
Publicado: (2019)

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial
por: Yap, Timothy A., et al.
Publicado: (2022)

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022)

Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial
por: Rodon Ahnert, J., et al.
Publicado: (2023)

Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in France
por: Yahi, Feriel, et al.
Publicado: (2022)

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial
por: Lesueur, Paul, et al.
Publicado: (2020)

A Phase I trial of talazoparib in patients with advanced hematologic malignancies
por: Gopal, Ajay K, et al.
Publicado: (2021)

Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial
por: Schram, Alison M., et al.
Publicado: (2022)

Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital
por: Quilan, Florian, et al.
Publicado: (2023)

Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
por: Lange, Marie, et al.
Publicado: (2022)

Cognitive complaints in cancer survivors and expectations for support: Results from a web–based survey
por: Lange, Marie, et al.
Publicado: (2019)

Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2
por: Quak, Elske, et al.
Publicado: (2021)

Evidence to date: talazoparib in the treatment of breast cancer
por: Exman, Pedro, et al.
Publicado: (2019)

Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation
por: Lesueur, Paul, et al.
Publicado: (2018)

Retentissement de la pandémie de COVID-19 sur la prise en charge oncologique des patients : résultats de l’étude COVIPACT
por: Lequesne, J., et al.
Publicado: (2021)

Stress post-traumatique chez les patients traités pour un cancer au cours de la pandémie COVID-19 : résultats de l’étude COVIPACT
por: Lefevre-Arbogast, S., et al.
Publicado: (2021)

Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
por: Lange, Marie, et al.
Publicado: (2017)

Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
por: Lange, Marie, et al.
Publicado: (2018)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial
por: You, Benoit, et al.
Publicado: (2020)

Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy
por: Chin, K., et al.
Publicado: (2017)

A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
por: Brown, Landon C., et al.
Publicado: (2022)

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)
por: Dos Santos, Mélanie, et al.
Publicado: (2022)

Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors
por: Boscher, Clémence, et al.
Publicado: (2020)

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study
por: Bardet, Stéphane, et al.
Publicado: (2020)

The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer
por: Cherifi, François, et al.
Publicado: (2022)

Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
por: Tintelnot, Joseph, et al.
Publicado: (2022)

Avelumab demonstrates promise in advanced NSCLC
por: Marciscano, Ariel E., et al.
Publicado: (2017)

Evaluation of the potential for QTc prolongation with avelumab
por: Vugmeyster, Yulia, et al.
Publicado: (2019)

Multimodal Web-Based Intervention for Cancer-Related Cognitive Impairment in Breast Cancer Patients: Cog-Stim Feasibility Study Protocol
por: Binarelli, Giulia, et al.
Publicado: (2021)

LBA69 Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients
por: Joly, F., et al.
Publicado: (2020)

Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
por: Boussios, Stergios, et al.
Publicado: (2020)

Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
por: Li, Jiaguo, et al.
Publicado: (2020)

Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer
por: Klein, Florian G., et al.
Publicado: (2021)

Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
por: Zhou, Dong, et al.
Publicado: (2021)

PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
por: Jonuscheit, Stephanie, et al.
Publicado: (2021)

Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol
por: Elia, Clara, et al.
Publicado: (2023)

(18)F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study
por: Ciappuccini, Renaud, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_spe28plsegnsainof5hqcufsiv